Lana Meyer
Nurse Practitioner · Melbourne, FLNPI 1275590044
Payments from drug & device makers
Across 65 payments — averaging $22.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Teva Pharmaceuticals USA, Inc.$417
- AbbVie$300
- Pfizer$80
- Lilly USA, LLC$66
- Sanofi$60
- UCB, Inc.$56
- plus $457 from 16 others
What the payments were for
- Food & beverage$1,34694%
- Education$886%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 13 | $417 |
| AbbVie | 16 | $300 |
| Pfizer | 4 | $80 |
| Lilly USA, LLC | 3 | $66 |
| Sanofi | 4 | $60 |
| UCB, Inc. | 3 | $56 |
| Otsuka America Pharmaceutical, Inc. | 2 | $45 |
| Biohaven Pharmaceuticals, Inc. | 1 | $44 |
| Neurelis, Inc. | 2 | $41 |
| EMD Serono, Inc. | 2 | $41 |
| SK Life Science, Inc. | 2 | $39 |
| Kyowa Kirin, Inc. | 2 | $37 |
| Corium, LLC | 2 | $33 |
| BD | 1 | $27 |
| Abiomed | 1 | $24 |
| Acadia Pharmaceuticals Inc | 1 | $22 |
| Jazz Pharmaceuticals Inc. | 1 | $21 |
| Eisai Inc. | 1 | $19 |
| Mallinckrodt Hospital Products Inc. | 1 | $18 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $17 |
| Amneal Pharmaceuticals LLC | 1 | $15 |
| Catalyst Pharmaceuticals, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- UBRELVY$124
How this compares
$1,434 in reported general payments places this provider in the 75th percentile of 8,290 nurse practitioner providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Memantine Hcl | 21 | $882 |
| Gabapentin | 18 | $690 |
| Levetiracetam | 11 | $674 |
| Lamotrigine | 11 | $129 |
| Donepezil Hcl | 12 | $64 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Melbourne
- Jolanta BaginskiClearwater$494K
- Adissa PerezWinter Park$370K
- April WessonTampa$342K
- Margarita FernandezMiami$311K
- Stephanie SimmermanNaples$283K
- Claudette WalkerPonte Vedra Beach$271K
- Lisa NodzonTampa$246K
- Ashima BahlTampa$226K
- Maya BloombergMiami$202K
- Jennifer PuleoTampa$171K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.